Projects per year
Organisation profile
Fields of science
- 302024 Haematology
- 302055 Oncology
Profiles
-
CANDOR : Cancer Odor
Narzt, W. (Researcher), Schmitt, C. (Researcher), Ghanem, R. (Researcher) & Langer, R. (Researcher)
01.02.2025 → 31.07.2025
Project: Clinical studies › Clinical Study (Funded research)
-
Circulating tumor DNA based decision for adjuvant treatment in colon cancer stage II evaluation
Ghanem, R. (Researcher), Kausche, L. (Researcher), Klein, K. (Researcher), Kovacsova, J. (Researcher), Krenosz, K. J. (Researcher), Krivic, D. (Researcher), Kühr, T. (Researcher), Popp, H. D. (Researcher), Schmitt, C. (Researcher), Schneeweiß, B. (Researcher), Schwarz, H. (Researcher), Solomianyi, O. (Researcher), Stegemann, M. (Researcher) & Piringer, G. (PI)
12.11.2024 → 31.12.2027
Project: Clinical studies › Clinical Study (Industry project)
-
A Phase 3 Randomized, Active-controlled, Open-label, Multicenter Study to Compare the Efficacy and Safety of MK-2870 Monotherapy Versus Treatment of Physician’s Choice as Second-line Treatment for Participants with Recurrent or Metastatic Cervical Cancer (MK-2870-020)
Ghanem, R. (Researcher), Kausche, L. E. (Researcher), Klein, K. (Researcher), Kovacsova, J. (Researcher), Krenosz, K. J. (Researcher), Krivic, D. (Researcher), Kühr, T. (Researcher), Lichtenauer, N. (Researcher), Piringer, G. (Researcher), Popp, H. D. (Researcher), Preuß, C. I. (Researcher), Schmitt, C. (Researcher), Schneeweiß, B. (Researcher), Solomianyi, O. (Researcher), Stegemann, M. (Researcher) & Schwarz, H. K. (PI)
07.11.2024 → 06.11.2029
Project: Clinical studies › Clinical Study (Industry project)
-
Author Correction: Virus-induced senescence is a driver and therapeutic target in COVID-19
Lee, S., Yu, Y., Trimpert, J., Benthani, F., Mairhofer, M., Richter-Pechanska, P., Wyler, E., Belenki, D., Kaltenbrunner, S., Pammer, M., Kausche, L., Firsching, T. C., Dietert, K., Schotsaert, M., Martínez-Romero, C., Singh, G., Kunz, S., Niemeyer, D., Ghanem, R. & Salzer, H. J. F. & 28 others, , Feb 2025, In: Nature. 638, 8052, p. E46Research output: Contribution to journal › Article › peer-review
-
Chronic Stress Stimulates Protumor Macrophage Polarization to Propel Lung Cancer Progression
Liu, C., Du, H., Yu, G., Qi, J., Dong, H., Hu, R., Wang, F., Cui, B., Chen, W., Zhang, Q., Li, C., Gao, R., Schmitt, C. A., Deng, J., Yu, Y. & Du, J., 09 Apr 2025, (E-pub ahead of print) In: Cancer research.Research output: Contribution to journal › Article
-
Neoadjuvant atezolizumab in combination with dual HER2 blockade plus epirubicin in women with early HER2-positive breast cancer: the randomized phase 2 ABCSG-52/ATHENE trial
Rinnerthaler, G., Egle, D., Bartsch, R., Schmitt, C. A., Petzer, A., Balic, M., Petru, E., Denison, U., Singer, C. F., Bjelic-Radisic, V., Gampenrieder, S. P., Knauer, M., Sotlar, K., Brunner, C., Posch, F., Hlauschek, D., Sölkner, L., Bago-Horvath, Z., Filipits, M. & Gili, M. & 10 others, , Jan 2025, In: Nature Cancer. 6, 1, p. 41-50 10 p.Research output: Contribution to journal › Article › peer-review
Open Access
Activities
-
Simultaneous auto-transplant and CD19 CAR T-cell 2L therapy followed by a CD20 x CD3 bispecific antibody in a patient with refractory Burkitt lymphoma
Stegemann, M. (Speaker)
03 Dec 2024Activity: Talk or presentation › Poster presentation › science-to-science
-
T-NHL
Stegemann, M. (Speaker)
01 Nov 2024Activity: Talk or presentation › Contributed talk › science-to-science
-
Aggressive und indolente NHL
Stegemann, M. (Speaker)
22 Oct 2024Activity: Talk or presentation › Contributed talk › science-to-science